vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
COLLEGIUM PHARMACEUTICAL, INC的季度营收约是ROGERS CORP的1.0倍（$205.4M vs $200.5M），COLLEGIUM PHARMACEUTICAL, INC净利率更高（8.3% vs 2.2%，领先6.0%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 5.2%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $1.1M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs -3.3%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
COLL vs ROG — 直观对比
营收规模更大
COLL
是对方的1.0倍
$200.5M
营收增速更快
COLL
高出7.7%
5.2%
净利率更高
COLL
高出6.0%
2.2%
自由现金流更多
COLL
多$121.3M
$1.1M
两年增速更快
COLL
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $200.5M |
| 净利润 | $17.0M | $4.5M |
| 毛利率 | 62.5% | 32.2% |
| 营业利润率 | 29.6% | — |
| 净利率 | 8.3% | 2.2% |
| 营收同比 | 12.9% | 5.2% |
| 净利润同比 | 35.3% | 421.4% |
| 每股收益（稀释后） | $0.48 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COLLROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $205.4M | $201.5M | ||
| Q3 25 | $209.4M | $216.0M | ||
| Q2 25 | $188.0M | $202.8M | ||
| Q1 25 | $177.8M | $190.5M | ||
| Q4 24 | $181.9M | $192.2M | ||
| Q3 24 | $159.3M | $210.3M | ||
| Q2 24 | $145.3M | $214.2M |
净利润COLLROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $17.0M | $4.6M | ||
| Q3 25 | $31.5M | $8.6M | ||
| Q2 25 | $12.0M | $-73.6M | ||
| Q1 25 | $2.4M | $-1.4M | ||
| Q4 24 | $12.5M | $-500.0K | ||
| Q3 24 | $9.3M | $10.7M | ||
| Q2 24 | $19.6M | $8.1M |
毛利率COLLROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 62.5% | 31.5% | ||
| Q3 25 | 61.7% | 33.5% | ||
| Q2 25 | 57.7% | 31.6% | ||
| Q1 25 | 54.8% | 29.9% | ||
| Q4 24 | 54.0% | 32.1% | ||
| Q3 24 | 60.8% | 35.2% | ||
| Q2 24 | 62.5% | 34.1% |
营业利润率COLLROG
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | 3.5% | ||
| Q3 25 | 29.7% | 7.3% | ||
| Q2 25 | 18.7% | -33.3% | ||
| Q1 25 | 12.2% | -0.2% | ||
| Q4 24 | 20.9% | -6.6% | ||
| Q3 24 | 21.9% | 6.9% | ||
| Q2 24 | 32.7% | 5.3% |
净利率COLLROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 8.3% | 2.3% | ||
| Q3 25 | 15.0% | 4.0% | ||
| Q2 25 | 6.4% | -36.3% | ||
| Q1 25 | 1.4% | -0.7% | ||
| Q4 24 | 6.9% | -0.3% | ||
| Q3 24 | 5.9% | 5.1% | ||
| Q2 24 | 13.5% | 3.8% |
每股收益（稀释后）COLLROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $0.48 | $0.20 | ||
| Q3 25 | $0.84 | $0.48 | ||
| Q2 25 | $0.34 | $-4.00 | ||
| Q1 25 | $0.07 | $-0.08 | ||
| Q4 24 | $0.36 | $-0.04 | ||
| Q3 24 | $0.27 | $0.58 | ||
| Q2 24 | $0.52 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $301.7M | $1.2B |
| 总资产 | $1.7B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COLLROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $386.7M | $197.0M | ||
| Q3 25 | $285.9M | $167.8M | ||
| Q2 25 | $222.2M | $157.2M | ||
| Q1 25 | $197.8M | $175.6M | ||
| Q4 24 | $162.8M | $159.8M | ||
| Q3 24 | $120.0M | $146.4M | ||
| Q2 24 | $271.6M | $119.9M |
股东权益COLLROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $301.7M | $1.2B | ||
| Q3 25 | $274.8M | $1.2B | ||
| Q2 25 | $232.2M | $1.2B | ||
| Q1 25 | $234.4M | $1.3B | ||
| Q4 24 | $228.8M | $1.3B | ||
| Q3 24 | $234.3M | $1.3B | ||
| Q2 24 | $216.6M | $1.3B |
总资产COLLROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.6B | $1.4B | ||
| Q2 25 | $1.6B | $1.5B | ||
| Q1 25 | $1.6B | $1.5B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.1B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $122.4M | $1.1M |
| 自由现金流率自由现金流/营收 | 59.6% | 0.5% |
| 资本支出强度资本支出/营收 | 0.3% | 2.3% |
| 现金转化率经营现金流/净利润 | 7.25× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $327.6M | $70.1M |
8季度趋势，按日历期对齐
经营现金流COLLROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $123.0M | $46.9M | ||
| Q3 25 | $78.4M | $28.9M | ||
| Q2 25 | $72.4M | $13.7M | ||
| Q1 25 | $55.4M | $11.7M | ||
| Q4 24 | $84.6M | $33.7M | ||
| Q3 24 | $-9.0M | $42.4M | ||
| Q2 24 | $67.4M | $22.9M |
自由现金流COLLROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $122.4M | $42.2M | ||
| Q3 25 | $78.3M | $21.2M | ||
| Q2 25 | $72.4M | $5.6M | ||
| Q1 25 | $54.6M | $2.1M | ||
| Q4 24 | $84.1M | $18.3M | ||
| Q3 24 | $-9.2M | $25.2M | ||
| Q2 24 | $67.1M | $8.8M |
自由现金流率COLLROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 59.6% | 20.9% | ||
| Q3 25 | 37.4% | 9.8% | ||
| Q2 25 | 38.5% | 2.8% | ||
| Q1 25 | 30.7% | 1.1% | ||
| Q4 24 | 46.2% | 9.5% | ||
| Q3 24 | -5.8% | 12.0% | ||
| Q2 24 | 46.2% | 4.1% |
资本支出强度COLLROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.3% | 2.3% | ||
| Q3 25 | 0.1% | 3.6% | ||
| Q2 25 | 0.0% | 4.0% | ||
| Q1 25 | 0.4% | 5.0% | ||
| Q4 24 | 0.3% | 8.0% | ||
| Q3 24 | 0.2% | 8.2% | ||
| Q2 24 | 0.2% | 6.6% |
现金转化率COLLROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 7.25× | 10.20× | ||
| Q3 25 | 2.49× | 3.36× | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | 3.96× | ||
| Q2 24 | 3.44× | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
